Related Experiment Videos
Pharmacologic mechanisms of nitrates in myocardial ischemia
1Cardiovascular Division, University of Minnesota Medical School, Minneapolis 55455.
Insights
Nitrates offer cardiovascular benefits through hemodynamic and nonhemodynamic mechanisms, improving blood flow and inhibiting detrimental cell growth in myocardial ischemia patients.
Area of Science:
- Cardiology
- Pharmacology
- Vascular Biology
Background:
- Myocardial ischemia is associated with abnormal endothelial function.
- Nitrate medications are commonly used for managing ischemic heart conditions.
Purpose of the Study:
- To elucidate the hemodynamic and nonhemodynamic mechanisms of nitrate action in myocardial ischemia.
- To explore nitrates as a potential replacement for deficient endogenous vascular activity.
Main Methods:
- Review of existing literature on nitrate pharmacology and cardiovascular effects.
- Analysis of hemodynamic parameters influenced by nitrates.
- Examination of nonhemodynamic effects on vascular and cardiac cells.
Main Results:
- Nitrates induce arterial relaxation, increased compliance, and venous capacitance.
- They promote collateral vessel dilation and potentially enhance myocardial compliance.
- Evidence suggests inhibition of vascular smooth muscle growth and cardiac remodeling.
Conclusions:
- Nitrates provide therapeutic benefits in myocardial ischemia via dual mechanisms.
- Their effects mimic endogenous endothelium-derived relaxing factor, compensating for deficiencies.
Abstract:
Nitrates exert both hemodynamic and nonhemodynamic effects that help explain the mechanisms by which these drugs benefit patients with myocardial ischemia. The hemodynamic effects of nitrates include relaxation of conduit arteries, increased arterial compliance, increased venous capacitance, dilation of collateral vessels in the myocardium, and, possibly, increased myocardial compliance. A growing body of evidence suggests that the nonhemodynamic effects of these agents include inhibition of vascular smooth muscle growth and of myocyte hypertrophy and ventricular remodeling. Since endothelial function appears to be abnormal in patients with myocardial ischemia and nitrates replicate many of the effects of endothelium-derived relaxing factor, these drugs may be viewed as a pharmacologic replacement for deficient endogenous activity.